MAPT and neurodegenerative disease: Additionally, given the importance of developing structure-guided molecular diagnostics and therapeutics that target tau filaments to more precisely define pathologies that arise in DS and in neurodegenerative diseases, we were motivated to characterize tau filament structures that develop in individuals with DS.